An RSO must report a misadministration in nuclear medicine to the NRC when:
-
A
Any dose differs from the prescribed dose by more than 5%
-
B
The administered dose exceeds the prescribed dose by defined thresholds (e.g., >20% for therapeutic doses) or involves the wrong patient/radionuclide
-
C
The patient reports any adverse symptoms after administration
-
D
The NRC is notified automatically through the hospital's EMR system